Startup

Biograil

Oral delivery of biologics via the BIONDD capsule device

  • Biotech & Life Sciences
  • Roskilde, Denmark
  • 2019

About Biograil

Biograil is a pre-clinical stage Danish pharmaceutical company founded in 2019 and based in Roskilde. Its BIONDD platform is a mechanical device inside a standard swallowable capsule that delivers drugs into the stomach wall, aiming to replace injections for biologics. The company works with partners such as CSL and is backed by Verve Ventures, Megatrend Invest, HTGF and Evonik Venture Capital. In November 2026 it raised EUR 20 million to prepare clinical trials.

Founders

  • Karsten Lindhardt

    CEO & Founder

    Former Chief Scientific Officer of Egalet.

  • Nikolaj Skak

    CSO & Founder

Biograil logo
Industry
Biotech & Life Sciences
Based in
Roskilde, Denmark
Founded
2019

Funding rounds

DateRoundAmountLead investors
Series B€20.0m—